Witnessing the stock’s movement on the chart, on Wednesday, Monte Rosa Therapeutics Inc (NASDAQ: GLUE) had a quiet start as it plunged -8.20% to $5.99,
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) on Monday, plunged -3.91% from the previous trading day, before settling in for the closing price of $7.17. Within
On Monday, Monte Rosa Therapeutics Inc (NASDAQ: GLUE) was 3.03% up from the session before settling in for the closing price of $6.93. A 52-week
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) started the day on Wednesday, with a price decrease of -8.34% at $7.03, before settling in for the price
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) on Friday, plunged -2.95% from the previous trading day, before settling in for the closing price of $7.79. Within
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) open the trading on Wednesday, with a bit cautious approach as it glided -9.85% to $8.51, before settling in
On Friday, Monte Rosa Therapeutics Inc (NASDAQ: GLUE) was 6.57% up from the session before settling in for the closing price of $8.83. A 52-week
On Tuesday, Monte Rosa Therapeutics Inc (NASDAQ: GLUE) opened lower -3.52% from the last session, before settling in for the closing price of $10.22. Price
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) established initial surge of 5.93% at $9.11, before settling in for the price of $8.60 at the close. Taking
Monte Rosa Therapeutics Inc (NASDAQ: GLUE) on Friday, plunged -8.73% from the previous trading day, before settling in for the closing price of $8.48. Within
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
